RLYBRallybio Corp
Health Care
Revenues revised up 6.0% for FY 2024
Revenues·FY 2024
Notable restatement$636K▲ 6.0%
was$600K
Revised up. Any P/S built on the original was 5.7% too high.
Verify against SEC filingsShow
As reported$600K
Accepted 2025-03-130001739410-25-000040
Restated$636K
Accepted 2026-08-260001193125-26-368568
TotalRevenue · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time RLYB — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.